Core Viewpoint - The controlling shareholder of Weijian Medical, Weijian Group Co., Ltd., has expressed confidence in the company's future development and has voluntarily extended the lock-up period for two consecutive years after the IPO lock-up expiration, which will end on September 16, 2025 [2] Summary by Relevant Sections - **Shareholder Commitment** - The controlling shareholder has committed to extending the lock-up period voluntarily for two years post-IPO [2] - The lock-up period is set to expire on September 16, 2025 [2] - **Business Outlook** - The controlling shareholder is optimistic about the development of the two main business segments: "medical" and "consumer" [2] - There are currently no plans for share reduction after the lock-up period expires [2] - **Disclosure Compliance** - If there are future plans for share reduction by the controlling shareholder, the company will ensure compliance with legal and regulatory requirements for timely and accurate information disclosure [2]

Core Viewpoint - The company is committed to enhancing its operational performance and shareholder value, indicating a proactive approach to management and strategic decision-making [2] Summary by Relevant Sections - **Stock Buyback Plan**: The company will consider a stock buyback plan based on market conditions and operational status, emphasizing a cautious and strategic approach to capital management [2] - **Regulatory Compliance**: Any potential stock buyback plan will adhere strictly to regulatory requirements, ensuring that the company follows proper procedures and timely disclosures to investors [2]

Core Viewpoint - On September 24, 2025, the company announced the election of Ms. Zhang Yan as the employee representative director of the fourth board of directors during the employee representative meeting [1] Group 1 - The employee representative meeting was held on September 24, 2025 [1] - Ms. Zhang Yan was elected as the employee representative director [1]

北京市中伦（深圳）律师事务所 关于稳健医疗用品股份有限公司 2025 年第一次临时股东会的 法律意见书 致：稳健医疗用品股份有限公司 北京市中伦（深圳）律师事务所 关于稳健医疗用品股份有限公司 2025 年第一次临时股东会的 法律意见书 二〇二五年九月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 一、 本次股东会的召集和召开程序 （一） 本次股东会的召集 为召开本次股东会，公司董事会于 2025 年 8 月 22 日在巨潮资讯网 （http://www.cninfo.com.cn/）上公告了《稳健 ...

特此公告。 稳健医疗用品股份有限公司董事会 二〇二五年九月二十四日 附件：职工代表董事简历 证券代码：300888 证券简称：稳健医疗 公告编号：2025-030 稳健医疗用品股份有限公司 关于选举职工代表董事的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没 有虚假记载、误导性陈述或重大遗漏。 稳健医疗用品股份有限公司（以下简称"公司"）根据《中华人民共和国公 司法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律 监管指引第 2 号——创业板上市公司规范运作》等法律法规、规范性文件及《公 司章程》等有关规定，公司董事会设职工代表董事一名。公司于 2025 年 9 月 24 日召开职工代表大会，经与会职工代表审议，同意选举张燕女士（简历详见附件） 为公司第四届董事会职工代表董事。 张燕女士由第四届董事会非独立董事变更为第四届董事会职工代表董事，任 期自本次职工代表大会审议通过之日起至第四届董事会任期届满之日止。本次选 举完成后，公司董事会中兼任公司高级管理人员以及由职工代表担任的董事人数 总计未超过公司董事总人数的二分之一，符合相关法律法规及《公司章程》等规 定。 张燕女士 ...

证券代码：300888 证券简称：稳健医疗 公告编号：2025-029 （二）会议召集人：公司董事会 （三）会议召开时间： 1.现场会议召开时间：2025 年 9 月 24 日（星期三）下午 14:30； 2.网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 9 月 24 日的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00； 稳健医疗用品股份有限公司 2025 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东会无增加、变更、否决议案的情况； 2.本次股东会未涉及变更以前股东会决议的情形。 一、会议召开和出席情况 （一）股东会届次：2025 年第一次临时股东会 通过深圳证券交易所互联网投票系统（http://wltp.cninfo.com.cn）投票的具 体时间为：2025 年 9 月 24 日 9:15-15:00。 （四）会议召开地点：广东省深圳市龙华区民治街道北站社区汇隆商务中心 2 号楼 42 层。 （五）会议召开方式：采取现场投票与网络投票 ...

证券代码：300888 证券简称：稳健医疗 公告编号：2025-031 稳健医疗用品股份有限公司 关于公司部分董事、监事和高级管理人员 变更持股方式实施完成的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次持股方式变更实施完成系公司部分董事、监事和高级管理人员通过 大宗交易方式受让其本人通过首次公开发行前员工持股平台间接持有的公司股 份，持股方式由间接持有变更为直接持有。 2、本次持股方式变更前后，其直接和间接持有公司股份的总数量及持股比 例均未发生变化，不涉及向市场增持或减持公司股份的情形。 3、本次持股方式变更不会导致公司控股股东或实际控制人发生变化。 稳健医疗用品股份有限公司（以下简称"公司"或"本公司"）于 2025 年 9 月 5 日在巨潮资讯网披露《关于公司部分董事、监事和高级管理人员拟变更持 股方式的提示性公告》（公告编号：2025-026），基于对公司未来长期发展的信 心，同时为了更加严格地履行股份锁定承诺，公司部分董事、监事和高级管理人 员拟通过大宗交易、非交易过户等方式受让其本人通过首次公开发行前员工持股 平台厦门 ...

Market Overview - The personal care products sector experienced a decline of 0.77% on September 24, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3853.64, up 0.83%, while the Shenzhen Component Index closed at 13356.14, up 1.8% [1] Stock Performance - Notable gainers in the personal care sector included: - Yiyi Co., Ltd. (依依股份) with a closing price of 29.81, up 6.12% [1] - Zhongshun Jiesang (中顺洁桑) at 8.29, up 2.09% [1] - Liangmian Needle (两面针) at 5.99, up 1.70% [1] - Conversely, Baiya Co., Ltd. (百亚股份) saw a decline of 2.61%, closing at 26.90 [2] Trading Volume and Capital Flow - The personal care products sector had a net outflow of 15.49 million yuan from institutional investors and 16.54 million yuan from retail investors, while there was a net inflow of 32.04 million yuan from individual investors [2] - The trading volume for Yiyi Co., Ltd. reached 73,000 hands with a transaction value of 214 million yuan [1] Capital Flow Analysis - Key capital flow insights include: - Yiyi Co., Ltd. had a net inflow of 6.27 million yuan from institutional investors, while retail investors saw a net outflow of 9.08 million yuan [3] - Reliable Co., Ltd. (可靠股份) experienced a net inflow of 6.14 million yuan from institutional investors but a net outflow of 4.62 million yuan from retail investors [3] - Zhongshun Jiesang faced a significant net outflow of 7.42 million yuan from institutional investors, while individual investors contributed a net inflow of 18.98 million yuan [3]

Core Viewpoint - The article discusses the operational and strategic developments of Shengjian Medical, highlighting its focus on automation, internationalization, and brand development in the medical and consumer sectors. Group 1: Company Operations - Shengjian Medical's Wuhan production base operates three production lines with a monthly capacity of 1,500-1,600 tons [4] - The company has achieved a high level of automation, resulting in a "dark factory" model where minimal staff is required [3] - The medical segment's revenue for the first half of 2025 reached 25.2 billion yuan, a year-on-year increase of 46.4% [6] Group 2: Financial Performance - In the first half of 2025, Shengjian Medical reported a revenue of 52.96 billion yuan and a net profit of 4.92 billion yuan, reflecting year-on-year growth of 31.31% and 28.07% respectively [6] - The consumer segment, represented by "Cotton Era," achieved a revenue of 27.5 billion yuan in the same period, growing by 20.3% [6] - The company's profit margin is currently around 9%, lower than the previous 12% level [7] Group 3: Strategic Goals - Shengjian Medical aims to increase its international brand presence, targeting a shift from 10% to 90% in self-owned brand sales in overseas markets over the next five years [4] - The company plans to enhance its product structure by focusing on high-end medical materials and expanding its consumer product lines [8] - Future growth points include expanding the "Cotton Era" brand into new product categories and international markets [10][14] Group 4: Market Expansion - Shengjian Medical's overseas sales revenue reached 14.3 billion yuan in the first half of 2025, marking an 81.3% increase [13] - The company has successfully penetrated markets in North America, Europe, and Asia, with its products gaining significant market share [13] - The company is cautious about overseas listings, focusing instead on domestic market growth and brand recognition [15]

Market Overview - Major market indices opened lower on September 24, with the oil and gas extraction and service sectors leading the gains, including stocks like Junyou Co., which hit the daily limit, and Tongyuan Petroleum and Keli Co. following suit [1] - Real estate stocks saw significant increases, with Shen Zhen Yi A, Shanghai Lingang, and Shibei Gaoxin also hitting the daily limit [1] - The film and cinema sector performed strongly, with Bona Film Group reaching the daily limit, alongside Huayi Brothers and Light Media [1] Industry Highlights - The cultivated diamond concept surged, with Huanghe Xuanfeng hitting the daily limit and Inno Laser and Power Diamond rising over 5% [2] - The storage chip sector saw notable gains, with Jiangfeng Electronics, Chengbang Co., and Tongfu Microelectronics all reaching the daily limit [3] New Stock Offering - Changjiang Energy Technology commenced subscription today with an issue price of 5.33 yuan. The company focuses on the design, research and development, manufacturing, and service of energy and chemical specialized equipment, including key products like electric desalination equipment, which is crucial for oil extraction and refining processes. The company has maintained the top market share in electric desalination equipment in China from 2021 to 2023 [4] Financing Activities - As of September 23, the total market financing balance was 2.40 trillion yuan, a decrease of 8.02 billion yuan from the previous trading day. A total of 478 stocks saw net financing purchases exceeding 10 million yuan, with 36 stocks having net purchases over 100 million yuan. Luxshare Precision topped the list with a net purchase of 1.352 billion yuan, followed by Shenghong Technology and Zhongji Xuchuang with 792 million yuan and 661 million yuan, respectively [5][7] Executive Shareholding - In the past 10 trading days (September 10 to September 23), there were 114 records of executive shareholding, involving 45 companies, with a total of 20.73 million shares and a total investment of 312 million yuan. The highest amount of executive shareholding was from Hand Information, with 5.0568 million shares and an investment of 91.2775 million yuan [8][9]